Investing.com - Viatris reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Viatris announced earnings per share of $-0.22 on revenue of $4.33B. Analysts polled by Investing.com anticipated EPS of $0.8285 on revenue of $4.35B.
Viatris shares are up 7.46% from the beginning of the year and are trading at $14.54 , down-from-52-week-high.They are outperforming the S&P 500 which is down 8.01% from the start of the year.
Viatris follows other major Healthcare sector earnings this month
Viatris's report follows an earnings matched by Roche Holding ADR on Thursday, February 3, 2022, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
Pfizer had beat expectations on Tuesday, February 8, 2022 with fourth quarter EPS of $1.08 on revenue of $23.84B, compared to forecast for EPS of $0.8742 on revenue of $24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar